Joseph W. Harding

Affiliations: 
Washington State University, Pullman, WA, United States 
Area:
hippocampus, dementia
Google:
"Joseph Harding"
Mean distance: 18.78 (cluster 32)
 

Children

Sign in to add trainee
J. A. Masino grad student 2003 WSU
Starla Meighan grad student 2003 WSU
Sean G. Sanders grad student 2003 WSU
Pete Meighan grad student 2006 WSU
Brent J. Yamamoto grad student 2006 WSU
Patrick D. Elias grad student 2008 WSU
Reka Natarajan grad student 2009 WSU
Alene McCoy grad student 2010 WSU
Caroline C. Benoist grad student 2011 WSU
Leen H. Kawas grad student 2011 WSU
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vanderwerff BR, Church KJ, Kawas LH, et al. (2019) Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma. Cytokine. 123: 154762
Wright JW, Church KJ, Harding JW. (2019) Hepatocyte Growth Factor and Macrophage-Stimulating Protein "Hinge" Analogs to Treat Pancreatic Cancer. Current Cancer Drug Targets
Wright JW, Harding JW. (2019) Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Church KJ, Vanderwerff BR, Riggers RR, et al. (2018) Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine. Anti-Cancer Drugs
Church KJ, Vanderwerff BR, Riggers RR, et al. (2016) Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells. Anti-Cancer Drugs
Uribe PM, Kawas LH, Harding JW, et al. (2015) Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure. Frontiers in Cellular Neuroscience. 9: 3
Wright JW, Harding JW. (2015) The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 985-1000
Wright JW, Kawas LH, Harding JW. (2015) The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology. 125: 26-46
Benoist CC, Kawas LH, Zhu M, et al. (2014) The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. The Journal of Pharmacology and Experimental Therapeutics. 351: 390-402
Natarajan R, Harding JW, Wright JW. (2013) A role for matrix metalloproteinases in nicotine-induced conditioned place preference and relapse in adolescent female rats. Journal of Experimental Neuroscience. 7: 1-14
See more...